Top Industry Leaders in the Anti Radiation Drugs Market
Latest Anti-Radiation Drugs Companies Update:
Amgen Nplate remains the only FDA-approved drug for ARS treatment, positioning Amgen as a key player in the market. The recent US government purchase further strengthens their position.
Anbex The company is developing HEMATO-STEM, a potential candidate for ARS treatment in late-stage clinical trials. Positive results could significantly impact the market landscape.
Chrysalis BioTherapeutics Acquired the exclusive US rights to PLG02, another late-stage ARS treatment candidate, potentially entering the market soon.
List of Anti-Radiation Drugs Key companies in the market
- Amgen Inc.
- Anbex Inc.
- Arco Pharmaceuticals LLC
- BTG International Inc.
- Cellphire, Inc.
- Chrysalis BioTherapeutics, Inc.
- Darnitsa
- Enzychem Lifesciences Corporation
- Humanetics Corporation
- Mission Pharmacal Company
- Myelo Therapeutics GmbH
- Partner Therapeutics
- Pluri Inc.